Cargando…

Salivary cortisol, dehydroepiandrosteronesulphate (DHEA–S) and testosterone in women with chronic migraine

Hypothalamus–pituitaryadrenal (HPA) axis activity was monitored in 20 women with chronic migraine (CM), previously affected by medication overuse headache (MOH), in comparison to healthy women (20 subjects) by measuring salivary cortisol, testosterone, dehydroepiandrosterone–sulphate (DHEA–S) levels...

Descripción completa

Detalles Bibliográficos
Autores principales: Patacchioli, F. R., Monnazzi, P., Simeoni, S., De Filippis, S., Salvatori, E., Coloprisco, G., Martelletti, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3451699/
https://www.ncbi.nlm.nih.gov/pubmed/16575505
http://dx.doi.org/10.1007/s10194-006-0274-6
_version_ 1782244382969167872
author Patacchioli, F. R.
Monnazzi, P.
Simeoni, S.
De Filippis, S.
Salvatori, E.
Coloprisco, G.
Martelletti, P.
author_facet Patacchioli, F. R.
Monnazzi, P.
Simeoni, S.
De Filippis, S.
Salvatori, E.
Coloprisco, G.
Martelletti, P.
author_sort Patacchioli, F. R.
collection PubMed
description Hypothalamus–pituitaryadrenal (HPA) axis activity was monitored in 20 women with chronic migraine (CM), previously affected by medication overuse headache (MOH), in comparison to healthy women (20 subjects) by measuring salivary cortisol, testosterone, dehydroepiandrosterone–sulphate (DHEA–S) levels, and their ratios, one week after the end of the MOH rehabilitation procedure. The participants were instructed how to collect saliva samples at home, a procedure that was performed twice a day (08:00 a.m. and 8:00 p.m.). Morning and evening levels of cortisol were significantly increased in CM patients with respect to controls. With regard to the cortisol/DHEA–S ratio, an inverse marker of psycho–physical wellbeing, CM women showed significantly higher values than controls. Moreover, testosterone/cortisol ratios (anabolic/catabolic index of physical performance) were significantly lower in CM patients than in controls. In the present study, CM appears not to be associated with an impairment of cortisol and DHEAS circadian fluctuation; however, CM patients present alterations in HPA axis function that might contribute to metabolic and psychological alterations that have also been associated with CM.
format Online
Article
Text
id pubmed-3451699
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher Springer-Verlag
record_format MEDLINE/PubMed
spelling pubmed-34516992012-11-29 Salivary cortisol, dehydroepiandrosteronesulphate (DHEA–S) and testosterone in women with chronic migraine Patacchioli, F. R. Monnazzi, P. Simeoni, S. De Filippis, S. Salvatori, E. Coloprisco, G. Martelletti, P. J Headache Pain Rapid Communication Hypothalamus–pituitaryadrenal (HPA) axis activity was monitored in 20 women with chronic migraine (CM), previously affected by medication overuse headache (MOH), in comparison to healthy women (20 subjects) by measuring salivary cortisol, testosterone, dehydroepiandrosterone–sulphate (DHEA–S) levels, and their ratios, one week after the end of the MOH rehabilitation procedure. The participants were instructed how to collect saliva samples at home, a procedure that was performed twice a day (08:00 a.m. and 8:00 p.m.). Morning and evening levels of cortisol were significantly increased in CM patients with respect to controls. With regard to the cortisol/DHEA–S ratio, an inverse marker of psycho–physical wellbeing, CM women showed significantly higher values than controls. Moreover, testosterone/cortisol ratios (anabolic/catabolic index of physical performance) were significantly lower in CM patients than in controls. In the present study, CM appears not to be associated with an impairment of cortisol and DHEAS circadian fluctuation; however, CM patients present alterations in HPA axis function that might contribute to metabolic and psychological alterations that have also been associated with CM. Springer-Verlag 2006-03-31 2006-04 /pmc/articles/PMC3451699/ /pubmed/16575505 http://dx.doi.org/10.1007/s10194-006-0274-6 Text en © Springer-Verlag Italia 2006
spellingShingle Rapid Communication
Patacchioli, F. R.
Monnazzi, P.
Simeoni, S.
De Filippis, S.
Salvatori, E.
Coloprisco, G.
Martelletti, P.
Salivary cortisol, dehydroepiandrosteronesulphate (DHEA–S) and testosterone in women with chronic migraine
title Salivary cortisol, dehydroepiandrosteronesulphate (DHEA–S) and testosterone in women with chronic migraine
title_full Salivary cortisol, dehydroepiandrosteronesulphate (DHEA–S) and testosterone in women with chronic migraine
title_fullStr Salivary cortisol, dehydroepiandrosteronesulphate (DHEA–S) and testosterone in women with chronic migraine
title_full_unstemmed Salivary cortisol, dehydroepiandrosteronesulphate (DHEA–S) and testosterone in women with chronic migraine
title_short Salivary cortisol, dehydroepiandrosteronesulphate (DHEA–S) and testosterone in women with chronic migraine
title_sort salivary cortisol, dehydroepiandrosteronesulphate (dhea–s) and testosterone in women with chronic migraine
topic Rapid Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3451699/
https://www.ncbi.nlm.nih.gov/pubmed/16575505
http://dx.doi.org/10.1007/s10194-006-0274-6
work_keys_str_mv AT patacchiolifr salivarycortisoldehydroepiandrosteronesulphatedheasandtestosteroneinwomenwithchronicmigraine
AT monnazzip salivarycortisoldehydroepiandrosteronesulphatedheasandtestosteroneinwomenwithchronicmigraine
AT simeonis salivarycortisoldehydroepiandrosteronesulphatedheasandtestosteroneinwomenwithchronicmigraine
AT defilippiss salivarycortisoldehydroepiandrosteronesulphatedheasandtestosteroneinwomenwithchronicmigraine
AT salvatorie salivarycortisoldehydroepiandrosteronesulphatedheasandtestosteroneinwomenwithchronicmigraine
AT colopriscog salivarycortisoldehydroepiandrosteronesulphatedheasandtestosteroneinwomenwithchronicmigraine
AT martellettip salivarycortisoldehydroepiandrosteronesulphatedheasandtestosteroneinwomenwithchronicmigraine